PreludeDx: Karuna Mittal

PreludeDx has appointed Karuna Mittal as director of research and development. Mittal's most recent research efforts were at Emory University School of Medicine where she investigated novel targeted cancer therapies using functional genomics. Her research expertise extends to a variety of oncology areas including biomarker and targeted therapy discovery in breast, prostate, ovarian, and head and neck cancer.